Nova Ltd. (NVMI) Stock Price & How to Invest

Nova Ltd. (NASDAQ and Tel Aviv: NVMI), headquartered in Rehovot, Israel, builds process-control metrology for semiconductor manufacturing. Metrology is measurement rather than inspection: instead of hunting for defects, Nova's systems characterize the dimensions, profiles, thin-film thickness, and material composition of structures on a wafer while it is still moving through the line. The portfolio splits into a Dimensional Metrology Division built on optical techniques (integrated and standalone optical critical dimension, or OCD, scatterometry) and a Materials Metrology Division built on x-ray methods, plus chemical metrology acquired with ancosys in 2022 and a modeling and analytics software layer that is arguably the real moat. A meaningful share of Nova's tools are integrated, meaning they are bolted directly onto another vendor's deposition or etch equipment, which makes Nova both a supplier to fabs and a partner to process-equipment makers. Customers are the logic foundries, memory makers, and packaging houses in Taiwan, Korea, Japan, China, and the United States, and manufacturing sits in Israel, Germany, and the United States, with a new Asian facility targeted to be operational by the end of 2026.

The investment picture is a compounding niche leader trading like one. Fiscal 2025 revenue was a record ~$880.6M, up ~31%, with GAAP net income of ~$259.2M. That momentum continued into 2026: ~$235.3M in the March quarter and ~$255.0M in the June quarter, the first time Nova crossed $250M in a quarter, with GAAP gross margin around 56.5% and GAAP operating margin around 30%. Guidance for the September 2026 quarter of ~$277M to ~$287M implies another step up. The balance sheet holds roughly $1.6B in cash, deposits, and marketable securities against $750M of zero-coupon convertible notes due 2030 issued at a ~35% conversion premium. Against that, the stock carries a forward P/E near 45x versus roughly 25x for the broader US semiconductor group, has traded between about $233 and $616 over the past year, and depends on a customer base where four customers and three territories each cleared 10% of product revenue. This is a business whose fundamentals have been excellent and whose share price has been volatile for reasons that have little to do with any single quarter.

Nova sells capital equipment into an industry that has historically swung hard in both directions, so a pause in leading-edge capex at any of the handful of customers that matter would show up in orders within a quarter or two, and the current multiple leaves little room for that. Concentration is real: four customers and three territories each represented at least 10% of product revenue, and China alone has been roughly 30% or more of the business even after declining from about 39%. That China exposure sits directly in the path of US, Dutch, and Japanese export controls plus tariff changes, none of which Nova controls. Operations, R&D, and a large share of manufacturing are concentrated in Israel, which carries geopolitical, mobilization, and logistics risk that the company itself flags at length in its 20-F. Competitively, KLA is far larger and holds the dominant share of metrology and inspection overall, while Onto Innovation and Camtek are pushing hard on the same advanced-packaging demand Nova is winning today, so share gains are not guaranteed to continue. Finally, the $750M convertible notes become dilutive to share count if the stock trades above the conversion price, and the shares have already traveled from roughly $233 to roughly $616 in a single year, which tells you how quickly sentiment on this name reprices.

8 analysts publish price targets on NVMI, averaging $603.38 against a $387.97 price as of August 2026, or +55.5%. The published targets run from $540.00 to $640.00, a narrow spread, and the ratings split 7 buy, 1 hold, 0 sell. Over the last six months there have been 7 raises and 0 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full NVMI forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Nova Ltd.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Gate-all-around and the rising metrology intensity of leading-edge logic. The industry's move from FinFET to gate-all-around transistors stacks nanosheet channels vertically, which creates buried structures that cannot be measured by looking at a wafer from above in the old way. The most optimistic published target, $640.00, assumes this works close to its best case.

The case against. Nova sells capital equipment into an industry that has historically swung hard in both directions, so a pause in leading-edge capex at any of the handful of customers that matter would show up in orders within a quarter or two, and the current multiple leaves little room for that. The most pessimistic target, $540.00, is roughly what NVMI is worth if this bites instead.

Read the full bull and bear case on NVMI, including what would have to change to break either one. Walnut is not an investment adviser.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Nova Ltd.'s investor relations page or your broker.

• Revenue (TTM): ~$903M (trailing figure, before the record June quarter fully rolls in)
• Q2 2026 revenue: ~$255.0M (+16% YoY, +8% QoQ, a company record)
• Gross margin (Q2 2026): ~56.5% GAAP, ~58% non-GAAP
• Operating margin (Q2 2026): ~30% GAAP, ~33% non-GAAP
• Diluted EPS (Q2 2026): ~$2.20 GAAP, ~$2.51 non-GAAP
• Q3 2026 guidance: revenue ~$277M to ~$287M, non-GAAP EPS ~$2.70 to ~$2.85

Market capitalization is roughly $12.5B on about 31.8M shares outstanding, which puts the stock near a 45x forward earnings multiple against roughly 25x for the average US semiconductor name, and above Nova's own 15-year average price-to-earnings ratio of about 37x. The premium is being paid for a record set of results, not a promise: fiscal 2025 revenue of ~$880.6M grew ~31% with GAAP net income of ~$259.2M, and both 2026 quarters so far set records with margins holding in the mid-50s. The offset is a 52-week range of roughly $233 to $616, which is the market repricing the same business by more than 2x inside a year as views on the leading-edge capex cycle shift.

Other names that sit close to NVMI: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get NVMI exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so NVMI sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where NVMI fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Nova is a small, exceptionally profitable niche leader riding the same leading-edge capex wave as its much larger peers, and the debate is almost entirely about whether a roughly 45x forward multiple already prices in several more years of that wave.

Whether NVMI is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is NVMI a buy or a sell?, and where the stock could go from here in the NVMI stock forecast.

For income investors, whether NVMI pays a dividend and how the payout looks is covered in does NVMI pay a dividend? And to weigh NVMI against a peer, read the full side-by-side comparisons: NVMI vs KLAC and NVMI vs AMAT.